loading

Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
48.34%
0.715
0.482 0.469 0.238 -
Cost Of Revenue
66.35%
7.261
4.365 4.34 2.05 -
Gross Profit
68.58%
-6.546
-3.883 -3.871 -1.812 -
Operating Expenses
5.28%
111.18
117.37 114.49 108.27 110.86
Benefits Costs and Expenses
2.97%
115.10
118.62 115.47 107.24 107.37
Costs And Expenses
2.71%
118.44
121.74 118.83 110.32 110.86
Operating Income/Loss
2.91%
-117.72
-121.26 -118.36 -110.09 -110.86
Income/Loss From Continuing Operations Before Tax
3.18%
-114.38
-118.14 -115.00 -107.00 -107.37
Income Tax Expense/Benefit, Deferred
19.95%
-1.408
-1.759 -1.243 - -
Income Tax Expense/Benefit
19.95%
-1.408
-1.759 -1.243 -0.477 -
Income/Loss From Continuing Operations After Tax
2.92%
-112.98
-116.38 -113.76 -106.53 -107.37
Net Income/Loss
2.92%
-112.98
-116.38 -113.76 -106.53 -107.37
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
216.82%
266.22
-227.88 245.82 224.48 213.69
Diluted Average Shares
216.82%
266.22
-227.88 245.82 224.48 213.69
Basic Earnings Per Share
6.67%
-0.42
-0.45 -0.46 -0.47 -0.50
Diluted Earnings Per Share
6.67%
-0.42
-0.45 -0.46 -0.47 -0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):